Literature DB >> 23201452

Acute and sub-chronic (28days) oral toxicity evaluation of hydroethanolic extract of Bridelia ferruginea Benth root bark in male rodent animals.

Batomayena Bakoma1, Bénédicte Berké, Kwashie Eklu-Gadegbeku, Amegnona Agbonon, Kodjo Aklikokou, Messanvi Gbeassor, Edmond E Creppy, Nicholas Moore.   

Abstract

The present investigation was carried out to evaluate the safety of hydro-ethanol extract of Bridelia ferruginea Benth (Euphorbiaceae) root bark. For acute toxicity study, a single dose of 2000 and 5000 mg/kg of the B. ferruginea root bark extract was given orally to healthy male Wistar rats and Balb/c mice. The animals were observed for mortality and clinical signs for 3 h and then daily for 14 days. In the sub-chronic toxicity study, the extract was administered orally at doses of 250, 500 and 1000 mg/kg/day for 28 days to male Wistar rats. Animals were sacrificed to examine their organs, and urine and blood serum were analyzed. In the acute toxicity study, B. ferruginea root bark extract caused neither significant visible signs of toxicity, nor mortality in Wistar rats and Balb/c mice. In sub-chronic toxicity study, administration of the B. ferruginea root bark extract at 250, 500, and 1000 mg/kg for 28 consecutive days to Wistar rats did not produce mortality. No significant differences were found in relative organ weights, biochemical studied parameters in treated groups compared to control group. No obvious histological changes were observed in organs of B. ferruginea extract treated animals compared to controls.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23201452     DOI: 10.1016/j.fct.2012.11.021

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  7 in total

1.  Curcumin-loaded self-nanomicellizing solid dispersion system: part II: in vivo safety and efficacy assessment against behavior deficit in Alzheimer disease.

Authors:  Ankit Parikh; Krishna Kathawala; Jintao Li; Chi Chen; Zhengnan Shan; Xia Cao; Xin-Fu Zhou; Sanjay Garg
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

2.  Toxicological evaluation of lactase derived from recombinant Pichia pastoris.

Authors:  Shiying Zou; Xiaoyun He; Yifei Liu; Delong Chen; Yunbo Luo; Kunlun Huang; Wei Zhang; Wentao Xu
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

3.  Toxicological evaluation of the aqueous stem bark extract of Bridelia ferruginea (Euphorbiaceae) in rodents.

Authors:  Olufunsho Awodele; Kennedy Iliya Amagon; John Agbo; Majeti Narasimha Vara Prasad
Journal:  Interdiscip Toxicol       Date:  2015-06

4.  Bridelia ferruginea Benth.; An ethnomedicinal, phytochemical, pharmacological and toxicological review.

Authors:  Genevieve Naana Yeboah; Frederick William Akuffo Owusu; Mary-Ann Archer; Michael Odoi Kyene; Doris Kumadoh; Frederick Ayertey; Susana Oteng Mintah; Peter Atta-Adjei Junior; Alfred Ampomah Appiah
Journal:  Heliyon       Date:  2022-08-23

5.  Safety of red ginseng oil for single oral administration in Sprague-Dawley rats.

Authors:  Min-Ji Bak; Kyu-Bong Kim; Mira Jun; Woo-Sik Jeong
Journal:  J Ginseng Res       Date:  2013-12-12       Impact factor: 6.060

6.  Self-nanomicellizing solid dispersion of edaravone: part II: in vivo assessment of efficacy against behavior deficits and safety in Alzheimer's disease model.

Authors:  Ankit Parikh; Krishna Kathawala; Jintao Li; Chi Chen; Zhengnan Shan; Xia Cao; Yan-Jiang Wang; Sanjay Garg; Xin-Fu Zhou
Journal:  Drug Des Devel Ther       Date:  2018-07-09       Impact factor: 4.162

7.  Antidepressant and Anxiolytic Effects and Subacute Toxicity of the Aerial Parts of Psychotria ankasensis J.B.Hall (Rubiaceae) in Murine Models.

Authors:  Francis Ackah Armah; Isaac Tabiri Henneh; Isaac Kingsley Amponsah; Robert Peter Biney; Fynn Malcolm; John Alake; Wisdom Ahlidja; Mustapha Abubakar Ahmed; Christian Kweku Adokoh; Genevieve Etornam Adukpo; Desmond Omane Acheampong; Peter K Gathumbi
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-18       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.